carlisle & Associates
generic drug updates News contact carlisle medical
generic drug updates
Generic Luvox® CR Launches
Released: 03/19/2013
By: Mike Partridge, RPh

On March 13, Par Pharmaceuticals received final FDA approval and launched the generic equivalent of Jazz Pharma’s Luvox® CR (fluvoxamine extended release) capsules.

Luvox® CR is indicated for the treatment of obsessive compulsive disorder (OCD), as defined in the DSM-IV. The brand item had U.S. annual sales of approximately $30M.

Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer